Key Insights

Highlights

Treatment Research

1 treatments under study, led by Newborn Genetic Screening And Whole Genome Sequencing

Research Leaders

19 sponsors active, led by University of Siena

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT06549218Not ApplicableRecruitingPrimary

Genetic Newborn Screening for Rare Diseases Within the Screen4Care Project

Showing all 1 trials

Research Network

Common Treatments

  • Newborn Genetic Screening And Whole Genome Sequencing1

Active Sponsors

  • University of Siena1
  • University Hospital Freiburg1
  • Hospital San Pietro Fatebenefratelli1
  • Municipal Hospital Karlsruhe1
  • Innovative Medicines Initiative1

Top Investigators

Activity Timeline